ArticleCancer innovation2024

Evaluation of the safety and efficiency of cytotoxic T cell therapy sensitized by tumor antigens original from T-ALL-iPSC in vivo.

Weiran Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.